IDH2 and cancer: A lot of studies have suggested that loss-of-function mutations in SDH complex and FH lead to accumulation of omcometabolites such as succinate and fumarate, and oncogenic mutations of IDH produces the oncometabolite 2-hydroxyglutarate (2-HG), which provides strong evidence to link abnormal metabolism with cancers [8,14–18].